baber/WOPTO huggingface dataset:
Patent AT-E209293-T1 (AT)
Inventor: SCHULZ HARALD DR-ING
IPC: E05F1/08
Filed: 1999-07-27
Granted: 2001-12-15
Abstract: The quarterlight assembly, at a window or glass facade, has at least one window frame (30) with a window pane (10) which moves parallel to the window frame in an initial deployment direction (A1). A second window pane (20) is deployed in a second movement direction (A2) parallel to the window frame. A drive system (40) moves the two window panes (10,20) in the opposing movement directions (A1,A2).
Patent AT-E270607-T1 (AT)
Inventor: WIERSCHKE LARRY D
IPC: B65G21/20
Filed: 1999-09-03
Granted: 2004-07-15
Abstract: A transport apparatus for handling rows of units of multi-ply material such as rolls of bathroom tissue or paper toweling and stacks of folding facial tissue or toweling includes a pair of movable shuttles which can be moved together to provide a bridge for conveying the units over an opening and which can be moved apart to provide a gap so that trim pieces or selected units can fall through the opening. When the shuttles are moved to an upstream position, the shuttles bridge the opening, and units can be moved over the shuttles and over the opening. When a trim piece or selected unit is positioned just upstream of the downstream shuttle, the downstream shuttle is moved in a downstream direction away from the upstream shuttle to provide a gap between the shuttles so that the trim piece or selected unit falls through the gap and the opening. The upstream shuttle can then be moved in a downstream direction toward the downstream shuttle to close the gap. <IMAGE>
Patent AT-E222865-T1 (AT)
Inventor: BLORET JEAN-PIERRE
IPC: B60K20/02
Filed: 1999-11-25
Granted: 2002-09-15
Abstract: The control cables (6a,6b) of a gearbox penetrate into the vehicle compartment (3) through an opening (13) in the sheet metal bodywork (12) and through an opening (15) passing through an acoustic insulation wall (14). The sealed passage (10) comprises a sheath (16) having at one end a lip (16a) which is supported against the external surface directed towards the compartment. At the sheath second end is a lip (16b) fastening on an edge (12a) of the bodywork opening. This opening is sealed by an assembly constituted from two sole plates (17,18) comprising peripheral edges which are superposed and fixed against the external surface of the bodywork by a cheek web (19) and bolts (20). Each sole plate comprises a profiled wall inside its peripheral edge and in the central part of this wall is a sleeve (21,22) for the passage of cables. The sleeves are supported in their axial extension and ensure a continuous passage of the cable as well as a separation of the profiled walls so as to provide a free space between the sole plates.
Patent AT-E293215-T1 (AT)
Inventor: PANKL GEROLD ING
IPC: F16B5/02
Filed: 1999-06-28
Granted: 2005-04-15
Abstract: The connecting rod is made up of two sections (1, 2). These are held together by two screws (4) with opposite threads which fit into bores (3', 3'') in the two parts with corresponding internal threads.
Patent AT-E262052-T1 (AT)
Inventor: MOSER EVA MARIA
IPC: B01J3/00
Filed: 1999-03-25
Granted: 2004-04-15
Abstract: The invention relates to a device for cleaning, activating, coating, processing, surface-finishing and/or treating two- or three-dimensional substrates, especially elongated substrates such as substrate strips or strip-shaped materials. Said device comprises at least one reaction chamber (25) in which a vacuum can be generated. One airlock chamber (51, 55) each is positioned upstream and/or downstream of the reaction chamber. A cylinder airlock (11, 13) through which the substrate (1) can be fed is positioned between the airlock chamber and the reaction chamber.
Patent AT-E467748-T1 (AT)
Inventor: OKLEJAS ELI
IPC: F04D1/06
Filed: 1999-02-24
Granted: 2010-05-15
Abstract: A pump has a thrust bearing has a casing with an inlet port and a discharge port. A shaft is positioned within the pump. A thrust bearing is coupled to the shaft. A pressure alterable bearing cavity is located within the casing. The pressure alterable cavity allows the axial thrust on the shaft from the impellers to be counteracted. The thrust bearing has an annular seal coupled with respect to the casing disc is coupled to the shaft and positioned adjacent the seal. The seal and the disc have a gap therebetween. A feedback pipe couples the bearing cavity to the inlet port. As the axial thrust acting on the shaft changes, the gap between the seal and the disc also changes. The changing of the gap changes the pressure within the bearing cavity. The disc and thus the shaft are repositioned in response to the change in the bearing cavity pressure change.
Patent AT-E405503-T1 (AT)
Inventor: VANBROCKLIN OWEN
IPC: B67D7/58
Filed: 1999-06-14
Granted: 2008-09-15
Abstract: A smooth actuating, non-throttling dispensing pump with a low force to actuate is provided. The pump will dispense a fluid at a pressure and flow velocity sufficient to allow the fluid to exit through the actuator in a fine particle spray. This action occurs when the actuator, depressed by the finger, moves a displacement piston downward pressurizing the fluid in the fluid chamber. When a predetermined pressure is reached, seals between the piston and stem open permitting the pressurized fluid to exit the fluid chamber through the actuator. The relationship of the frictional and spring forces plus the pressure acting on the piston and stem determines when and how the fluid is dispensed.
Patent AT-E245029-T1 (AT)
Inventor: PACCIARINI MARIA ADELE
IPC: C07H19/24
Filed: 1999-08-27
Granted: 2003-08-15
Abstract: The present invention relates to the use of methoxymorpholino doxorubicin for the treatment of a liver cancer; in particular, it refers to the intrahepatic administration of methoxymorpholino doxorubicin for use in the liver tumor therapy optionally in association with an agent which remains selectively in liver tumor after its injection through the hepatic artery.
Patent AT-E315410-T1 (AT)
Inventor: HEAVNER GEORGE A
IPC: C07K16/28
Filed: 1999-11-02
Granted: 2006-02-15
Abstract: Modified antibodies with improved pharmacokinetic properties are disclosed. The antibodies bind to one or more human integrin receptors selected from the group consisting of GPIIb/IIIa,  alpha <v> beta 3 and Mac-1, and comprise one to about six organic moieties which are covalently bonded to specific sites on the antibodies. The organic moieties can each independently be a hydrophilic polymeric group, a fatty acid group, a fatty acid ester group, a lipid group or a phospholipid group. Also disclosed is a method of treating a human with a disease or disorder in which cells expressing GPIIb/IIIa, alpha v beta 3 and/or Mac-1 play a pathophysiological role. The method comprises administering an effective amount of one or more antibodies of the invention to a human in need thereof.
Patent AT-E306429-T1 (AT)
Inventor: AGREN GOERAN
IPC: B65D5/22
Filed: 1999-12-03
Granted: 2005-10-15
Abstract: A device at a package comprises a bottom and walls protruding upwards therefrom. The package is formed by a foldable blank and comprises an arrangement for locking the package in its erected state. The locking arrangement comprises locking tips (25, 26; 32, 33) connected to a wall, which locking tips are located inside a cavity in an adjoining wall in the erected state of the package and arranged to lock the wall first mentioned by bearing upon an upper panel portion (21, 23) of the adjoining wall from the inside.
Patent AT-E312612-T1 (AT)
Inventor: SEIDMAN ERNEST G
IPC: A61K31/52
Filed: 1999-09-24
Granted: 2005-12-15
Abstract: The present invention provides a method of optimizing therapeutic efficacy a nd reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolite s in the patient having an immune-mediated gastrointestinal disorder.
Patent DE-719194-T1 (DE)
Inventor: DEROCHE KENNETH
IPC: B23C5/20
Filed: 1994-08-30
Abstract: The present invention relates to a cutting insert for a milling cutter. The cutting insert includes a main body having a top face and at least one elevated corner nose area formed on the top face. Extending around the elevated corner nose area and along an adjacent side face of the cutting insert is a cutting edge. The elevated corner nose area includes an angled chamfer that intersects with the cutting edge and a flat surface disposed inwardly of the angled chamfer. A pair of tapered lands extend from the flat surface toward a respective side face of the cutting insert where each of the tapered lands intersect with the cutting edge.
Patent ES-2172485-T1 (ES)
Inventor: SANSO' MARCO
IPC: A61K9/00
Filed: 2000-06-29
Abstract: Ophthalmic preparations are described in form of aqueous gels with a viscosity range between 400 and 800 cps including: at least one active principle; a gelling agent and at least 2 co-solubilising/co-gelling agents.
Patent ES-2216734-T1 (ES)
Title: Concentrador escalable de encaminamiento de agujero de gusano.
Inventor: REED COKE S
IPC: H04L12/56
Filed: 2001-10-19
Abstract: Estructura de interconexión que comprende: - una pluralidad de líneas de transmisión de datos (104); y - una pluralidad de nodos (102) dispuestos en la pluralidad de líneas de transmisión de datos; presentando las líneas de transmisión de datos una pluralidad de nodos para la entrada de datos procedentes del exterior de la estructura de interconexión; presentando las líneas de transmisión de datos un extremo de salida de datos que permite que los datos salgan del sistema; y comprendiendo la pluralidad de nodos los nodos A, B y X, y comprendiendo la pluralidad de líneas de transmisión de datos las líneas L1 y L2, pudiendo el nodo A en la línea L1 transmitir datos al nodo B, un sucesor inmediato del nodo A en la línea L1, y pudiendo el nodo A transmitir datos al nodo X en la línea de transmisión de datos L2, siendo la distancia desde el nodo X hasta el extremo de salida de datos de la línea de transmisión L2 inferior a la distancia desde el nodo B hasta el extremo de salida de datos de la línea de transmisión L1.
Patent ES-2049702-T1 (ES)
Title: Reactivo de diagnostico, sus aplicaciones en un proceso para la determinacion de un productos de analisis y dispositivo para la aplicacion de dicho proceso.
Inventor: SAMAKE HAMIDOU
IPC: G01N33/533
Filed: 1992-11-12
Abstract: REACTIVO DE DIAGNOSTICO Y SUS APLICACIONES EN UN PROCESO PARA LA DETERMINACION CUALITATIVA U CUANTITATIVA RAPIDA DE UN LIGANDO O PRODUCTO DE ANALISIS EN UN FLUIDO QUE HA DE SER SOMETIDO A PRUEBA ASI COMO DISPOSITIVO PARA APLICACION DE DICHO PROCESO. DICHO REACTIVO RESPONDE A LA SIGUIENTE FORMULA (I): L-R-S-COL-(S)N (I) EN LA QUE L REPRESENTA UNA SUSTANCIA DE ENLACE APTA PARA ENLAZARSE DE MANERA ESPECIFICA , BIEN CON UN LIGANDO A DETECTAR EN UN FLUIDO, BIEN CON RECEPTOR DE DICHO LIGANDO; R ES UN GRUPO REACTIVO QUE ASEGURA EL ENLACE ENTRE EL COLORANTE COL Y LA SUSTANCIA L, DICHO GRUPO R ES APTO PARA REACCIONAR POR ADICION, SUSTITUCION O CUALQUIER OTRA REACCION CON LA SUSTANCIA L; S CONSTITUYE EL SOPORTE DEL GRUPO REACTIVO Y ES DEL TIPO (XH)X(Y)Y-(Z)Z, EN LA QUE X REPRESENTA UN ATOMO DE NITROGENO, Y REPRESENTA UN GRUPO CO O UN GRUPO SO2, Z REPRESENTA UN GRUPO CH2, X E Y REPRESENTA = O 1, Y Z REPRESENTA O, 1 `0 2; COL ES UNA MOLECULA APTA PARA PRODUCIR UNA COLORACION; S REPRESENTA UNO O VARIOSGRUPOS SOLUBILIZANTES DE TIPO SO3X'', COOX'' O NX''+, EN LOS QUE X'' REPRESENTA UN ATOMO DE HIDROGENO O UN ATOMO DE METAL ALCALINO; N REPRESENTA 0 O 1.
Patent ES-2079334-T1 (ES)
Inventor: MEHROTRA PANKAJ K
IPC: B23B27/14
Filed: 1993-12-07
Abstract: Provided is a silicon nitride based ceramic which is particularly useful for use as a cutting tool in the high speed chip forming machining of metallic materials. The ceramic is preferably composed of at least 85 volume percent (v/o) beta silicon nitride phase and less than about 5 v/o intergranular phase. The ceramic has greater than 0.2 weight percent (w/o) magnesia, greater than 0.2 w/o yttria, where the sum of magnesia and yttria is less than 5 w/o.
Patent ES-2130103-T1 (ES)
Title: Bolsa de gas para un sistema de proteccion de ocupantes de vehiculos.
Inventor: NAGEL UWE
IPC: B60R21/16
Filed: 1998-03-13
Abstract: LA INVENCION SE REFIERE A UNA BOLSA DE GAS PARA UN SISTEMA PROTECTOR DE OCUPANTES DE VEHICULO QUE CONSTA DE DOS CAPAS DE UN RECORTE DE MATERIAL DE UNA PIEZA (20) QUE ESTAN SUPERPUESTAS, PLEGADAS Y UNIDAS ENTRE SI Y QUE PRESENTAN UNA SECCION PRINCIPAL (22) Y DOS SECCIONES DE BORDE (24, 26) REPLEGADOS. PARA FACILITAR LA FABRICACION DE UNA BOLSA DE GAS CON UNA SECCION PLANA UTILIZANDO UN RECORTE DE MATERIAL SENCILLO, LA INVENCION PROPONE INCLUIR AL MENOS UNA CINTA DE ENGANCHE (14) QUE UNA ENTRE SI LAS DOS CAPAS, QUE AMBAS SECCIONES DE BORDE (24, 26) ESTEN PLEGADAS POR EL MISMO LADO DE LA SECCION PRINCIPAL (22) Y QUE SUS BORDES LIBRES ESTEN UNIDOS ENTRE SI. EN AL MENOS UNO DE LOS BORDES LIBRES DE LA SECCION DE BORDE (24, 26) SE HA CONFORMADO UNA SOLAPA DE MATERIAL (28, 30) QUE ESTA UNIDA A LA SECCION PRINCIPAL (22) OPUESTA, FORMANDO ASI LA CINTA DE ENGANCHE (14).
Patent CY-1107642-T1 (CY)
Inventor: TROMBETTA ENNIO
IPC: A23L7/109
Filed: 2007-05-29
Abstract: An automatic pasta-cooker including a first cooking chamber (1) provided with a valve (2) for feeding raw pasta and with an underlying valve (3) for discharging cooked pasta, a second cooking chamber (12) arranged below the discharge valve (3) of the firs chamber (1) and provided at the bottom with a shutter (13) for discharging cooked pasta, each chamber being connected to a pipe (9) for supplying hot water produced by a boiler (8), to a pipe (19) for draining the cooking water and to a pipe (17) for draining vapor. The pipes (9, 17, 19) terminate into a heat exchanger (18) for pre-heating the mains water that a pump (23) feeds to the boiler (8) through a pipe (22). All the components are electrically connected to a command board controlled by a suitable software.
Patent CY-1107100-T1 (CY)
Inventor: KOCH MICHEL
IPC: C07D491/04
Filed: 2007-12-19
Abstract: Benzo pyarano[3,2-h]acridin-7-one cinnamate compounds (I) and their enantiomers, diastereoisomers, hydrates, solvates, acids, bases or addition salts are new. Benzo pyarano[3,2-h]acridin-7-one cinnamate compounds of formula (I) and their enantiomers, diastereoisomers, hydrates, solvates, acids, bases or addition salts are new. X, Y 1H, halo, OH, (1-6C) alkoxy, nitro, CN, (1-6C) alkyl (optionally substituted by one or more OH or halo), (2-6C) alkenyl or -NRaRb; either R-a, R-b : H or (1-6C) alkyl; or N-R-aR-b : a monocyclic or 5-7-membered heterocycle optionally having a second heteroatom of O or N in the cyclic system; Z : O or NR-c; R-c : H, (1-6C) alkyl, aryl or aryl-(1-6C)alkyl; Ar : (hetero)aryl; R 1, R 3, R 4H or (1-6C) alkyl; R 2H, (1-6C) alkyl, OR-a or NR-aR-b; R 5OR-c, NR-cR-d, W 1-C(W 2)-U 1-V 1, W-a-C(W 2)-W 3-T 1 or -Z-CO-CH=CHAr; W-a, W 3O or NR-c; W 2O; U 1(1-8C) alkylene or (2-8C) alkenylene; V 1H, (hetero) aryl, OR, CO 2R-c, COR-c, CON-aaR-bb, NR-aaR-bb, N(R-c)-CO 2R-cc or N(R-c)COR-cc; R-cc : R-c; either R-aa, R-bb : R-a, R-b or aryl-(1-6C)alkyl; or N-R-aaR-bb : N-R-aR-b; and T 1H, (1-6C) alkyl or (2-6C) alkenyl, aryl or aryl-(1-6C) alkyl (all optionally substituted by OR-c or NR-aaR-bb). where the aryl is phenyl or naphthyl optionally substituted by one or more substituents of (1-6C) alkyl (optionally substituted by one or more OH or halo), OH, halo, carboxy, NO 2, NH 2, or mono- or di-(1-6C) alkylamino, where the alkyl moiety is (1-6C) alkoxy, (1-6C) acyl or (1-6C) alkylcarbonyloxy; and the heteroaryl is 5-12-membered (monocyclic, aromatic or bicyclic with aromatic ring(s)), and has 1, 2 or 3 heteroatoms of O, N or S, and optionally substituted by one or more groups of halo, (1-6C) alkyl optionally substituted by one or more OH, halo, (1-6C) alkoxy or NH 2 optionally substituted by one or two (1-6C)alkyl. [Image] ACTIVITY : Cytostatic. MECHANISM OF ACTION : None given.
Patent CY-1107875-T1 (CY)
Title: Παραγωγα αμινοκινολινης και η χρηση τους ως συνδετες των α3 αδενοσινης
Inventor: ARANYI PETER
IPC: C07D409/12
Filed: 2008-02-04
Abstract: Οι χημικές ενώσεις του γενικού χημικού τύπου (I), και τα άλατα τους, τα διαλύματα τους, τα ισομερή τους (ταυτομερή, δεσμότροπα, οπτικώς ενεργά ισομερή) καθώς επίσης και τα άλατα και τα διαλύματα, είναι ισχυροί συνδέτες του Α3 υποδοχέα αδενοσίνης, κατά προτίμηση ανταγωνιστές.
Patent CY-1108490-T1 (CY)
Inventor: HELLBERG MARK R
IPC: A61P27/06
Filed: 2008-11-07
Abstract: The use of HMG-CoA reductase inhibitors (e.g., statins) to treat glaucoma, control intraocular pressure, preserve the trabecular meshwork, protect against ocular neurodegeneration and/or protect against glaucomatous retinopathy is described. The preferred HMG-CoA reductase inhibitors, which are statins having an RI value of 0.2 to 0.7 (e.g., pravastatin), are administered via topical application to the affected eye(s) of the patient.
Patent CY-1110145-T1 (CY)
Inventor: BERGMAN JAN
IPC: C07D487/04
Filed: 2010-06-29
Abstract: Novel substituted indoloquinoxalines of formula (I wherein R1 is hydrogen or represents one or more similar or different substituents in the positions 7 to 10 selected from the group halogen, lower alkyl/alkoxy, hydroxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, R2 represents similar or different C1-C4 alkyl substituents, X is CO or CH2, Y is OH, NH2, NH—(CH2)n—R3 wherein R3 represents lower alkyl, OH, NH2, NHR4 or NR5R6 wherein R4, R5 and R6 independently are lower alkyl or cyclo-alkyl and n is an integer of from 2 to 4, with the provision that when X is CH2, Y is OH or NH—(CH2)n—OH, and pharmacologically acceptable salts thereof are described. The compounds are useful as drugs for preventing and/or treating autoimmune diseases.
Patent CY-1110813-T1 (CY)
Title: Χημικες ενωσεις
Inventor: MCCOULL WILLIAM
IPC: C07D413/04
Filed: 2010-10-04
Abstract: Περιγράφονται ενώσεις του τύπου (I) όπου μεταβλητές ομάδες ορίζονται εντός η χρήση τους στην αναστολή του 11βHSD1, διαδικασίες για την παρασκευή αυτών και φαρμακευτικές συνθέσεις που τις περιέχουν.
Patent CY-1111047-T1 (CY)
Inventor: BRIGANDI RICHARD ANTHONY
IPC: A61P27/02
Filed: 2010-12-21
Abstract: The present invention is directed to methods of treating an ocular neovascular disorder in a mammal by administration of pyrimidine derivatives, benzodiazepinyl derivatives and pharmaceutical compositions containing the same. The invention encompasses methods of treating an ocular neovascular disorder by administration of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, (S)-3-oxo-8-[3-(pyridin-2-ylamino)-1-propyloxy]-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-2-benzazepine-4-acetic acid or salts or solvates thereof. Combination therapies for the treatment of ocular neovascular disorders are also encompassed.
Patent CY-1113221-T1 (CY)
Inventor: XIAN-MING ZENG
IPC: A61K31/58
Filed: 2011-05-06
Abstract: The present invention provides a process for preparing a particulate medicament that has greater homogeneity and a lower adhesion between the particles of the active ingredient and the carrier. The process comprises the steps of: (a) combining a pharmaceutically active ingredient in the form of an agglomerate of primary particles having an agglomerate particle size such that the agglomerate is capable of passing through a sieve having a mesh of 50-3000 .mu.m with a pharmaceutically acceptable particulate carrier, and (b) mixing the resultant material in a mixer to break up the agglomerate into primary particles dispersed in the pharmaceutically acceptable particulate carrier such that 90% or more of the pharmaceutically active ingredient exists as primary particles having a particle size of 50 .mu.m or less.
Patent CY-1114006-T1 (CY)
Title: Τοπικα σκευασματα συνενζυμου q10 και μεθοδοι χρησης
Inventor: HSIA SUNG LAN
IPC: A61P35/00
Filed: 2013-05-27
Abstract: Τοπικά σκευάσματα του CoQ10 περιορίζουν το ρυθμό αύξησης όγκου σε ζώο-υποκείμενο. Στα πειράματα που περιγράφονται στο κείμενο, το CoQ10 αυξάνει όπως δείχθηκε το ρυθμό απόπτωσης σε καλλιέργεια κυττάρων καρκίνου δέρματος όχι όμως σε φυσιολογικά κύτταρα. Επιπλέον, αποδείχθηκε ότι η αγωγή ζώων που φέρουν όγκο με τοπικό σκεύασμα του CoQ10 περιορίζει δραστικά το ρυθμό αύξησης όγκου στα ζώα.
Patent CY-1115012-T1 (CY)
Title: Μεθοδος συστηματικης εξετασης παρασκευασματων παρασιτου για αποτελεσματικοτητα στην αποτροπη και ελεγχο ασθενειων
Inventor: WEINSTOCK JOEL
IPC: A61K35/62
Filed: 2013-08-01
Abstract: Η εφεύρεση αφορά σε μια μέθοδο συστηματικής εξέτασης παρασκευάσματος ελμινθικού παρασίτου που επηρεάζει λειτουργία ρυθμιστικού Τ κυττάρου και μέθοδο θεραπείας μιας ασθένειας με μεταβολή μιας ρυθμιστικής δραστικότητας Τ κυττάρου μέσω της χορήγησης ενός παρασκευάσματος παρασίτου.
Patent CY-1116489-T1 (CY)
Title: Μη λιθοτριπτικη θεραπεια του λιθου του νεφρου
Inventor: MCDOUGAL W SCOTT
IPC: A61B17/22
Filed: 2015-02-04
Abstract: Μία πτυχή της παρούσας εφεύρεσης σχετίζεται με μία μέθοδο χρήσεως της περίσταλσης για να εξωθήσει ένα βύσμα πολυμερούς μέσω μίας κοιλότητας θηλαστικού, απομακρύνοντας κατ' αυτόν τον τρόπο οποιονδήποτε λίθο και/ή θραύσματα λίθου που είναι παρόντα στην κοιλότητα. Σε μία εφαρμογή, η μέθοδος χρησιμοποιείται ως μία εναλλακτική στην συμβατική λιθοτριψία. Σε μία άλλη εφαρμογή, η μέθοδος χρησιμοποιείται σε συνδυασμό με την λιθοτριψία, απομακρύνοντας κατ' αυτόν τον τρόπο τα μικρά θραύσματα λίθου, τα οποία προκύπτουν από τέτοιου είδους διεργασίες.
Patent CY-1117408-T1 (CY)
Title: Συσκευη εισπνοων με οδηγο ευθυγραμμισης διατρησης καψουλας
Inventor: DUNKLEY MICHAEL JOHN
IPC: A61M15/00
Filed: 2016-04-19
Abstract: Μια συσκευή εισπνοών περιλαμβάνει ένα περίβλημα που περιέχει έναν θάλαμο με μια ή περισσότερες εισόδους αέρα. Ο θάλαμος έχει το κατάλληλο μέγεθος να δεχτεί μια κάψουλα η οποία με τη σειρά της περιλαμβάνει ένα αερολυμένο φαρμακευτικό σκεύασμα. Η συσκευή εισπνοών περιλαμβάνει περαιτέρω έναν μηχανισμό διάτρησης μέσα στο περίβλημα. Ο μηχανισμός διάτρησης περιέχει έναν οδηγό ευθυγράμμισης και ένα μέλος διάτρησης, όπου ο οδηγός ευθυγράμμισης περιλαμβάνει μια επιφάνεια προσαρμοσμένη να έρχεται σε επαφή με την κάψουλα, ενώ το μέλος διάτρησης προωθείται μέσα στην κάψουλα προκειμένου να δημιουργήσει ένα άνοιγμα στην κάψουλα. Τουλάχιστον ένα μέρος της επιφάνειας γλιστρά σε μια γωνία στον διαμήκη άξονα της κάψουλας. Εναλλακτικά ή επιπλέον, η επιφάνεια μπορεί να διαθέτει μια ή περισσότερες προεξοχές. Μια απόληξη σχετίζεται με το περίβλημα. Η απόληξη μπορεί να έχει τέτοιο μέγεθος και σχήμα ώστε να χωρά στο στόμα ή στη μύτη ενός χρήστη, προκειμένου ο χρήστης να εισπνέει μέσω της απόληξης το αερολυμένο φαρμακευτικό σκεύασμα που έχει διεγείρει την κάψουλα. Ο οδηγός ευθυγράμμισης επιτρέπει πιο συνεπή διάτρηση της κάψουλας και μεγαλύτερη διάρκεια ζωής της συσκευής.